Global Thin Film Drugs Market Size, Status and Forecast 2019-2025
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The classification of Thin Film Drugs includes transdermal film, oral thin film and other types, and the proportion of transdermal film is about 72% in 2016, and the proportion is in increasing trend from 2012 to 2017.
Europe region is the largest supplier of Thin Film Drugs, with a revenue market share nearly 40% in 2016. North America is the second largest supplier of Thin Film Drugs, enjoying revenue market share nearly 34% in 2016. Asia-Pacific region enjoys a high growth rate of Thin Film Drugs.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
In 2018, the global Thin Film Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Thin Film Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thin Film Drugs development in United States, Europe and China.
The key players covered in this study
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Market segment by Type, the product can be split into
Transdermal Film
Oral Thin Film
Others
Market segment by Application, split into
Hospitals
Drugstores
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Thin Film Drugs status, future forecast, growth opportunity, key market and key players.
To present the Thin Film Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Thin Film Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The classification of Thin Film Drugs includes transdermal film, oral thin film and other types, and the proportion of transdermal film is about 72% in 2016, and the proportion is in increasing trend from 2012 to 2017.
Europe region is the largest supplier of Thin Film Drugs, with a revenue market share nearly 40% in 2016. North America is the second largest supplier of Thin Film Drugs, enjoying revenue market share nearly 34% in 2016. Asia-Pacific region enjoys a high growth rate of Thin Film Drugs.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
In 2018, the global Thin Film Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Thin Film Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thin Film Drugs development in United States, Europe and China.
The key players covered in this study
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Market segment by Type, the product can be split into
Transdermal Film
Oral Thin Film
Others
Market segment by Application, split into
Hospitals
Drugstores
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Thin Film Drugs status, future forecast, growth opportunity, key market and key players.
To present the Thin Film Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Thin Film Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
